Victoria Empson

2PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 05, 2025
Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV).

Jean-Jacques Kiladjian, Christoph Klade, Pencho Georgiev

|Aug 26, 2023
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment.

Heinz Gisslinger, Christoph Klade, Pencho Georgiev

Pageof 1

Frequent Collaborators

1 joint publications

Hans C Hasselbalch

1 joint publications

Robert Kralovics

1 joint publications

Jean-Jacques Kiladjian